4-Methylumbelliferone (4-MU)

Catalog No.S2256

4-Methylumbelliferone (4-MU) Chemical Structure

Molecular Weight(MW): 176.17

4-Methylumbelliferone is a hyaluronic acid (HA) synthesis inhibitor with an IC50 of 0.4 mM.

Size Price Stock Quantity  
In DMSO USD 90 In stock
USD 70 In stock
USD 210 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Purity & Quality Control

Biological Activity

Description 4-Methylumbelliferone is a hyaluronic acid (HA) synthesis inhibitor with an IC50 of 0.4 mM.
Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
COS1 cells NUj3OIJ5TnWwY4Tpc44h[XO|YYm= NVHLUXZkSWexbnnzeIlkKGGldHn2bZR6KHejczDk[ZRmem2rbnXkJIlvKEORU{GgZ4VtdHNidILhcpNn\WO2ZXSge4l1cCCJQVygOE1RWEGUIHfhcY1iKHKnY3XweI9zNCCHQ{WwQVAvODJzIN88US=> MVSxNlYyPzl{NB?=
CV-1 cells NIDzRZhHfW6ldHnvckBie3OjeR?= NEHicVRO[XirbXHsJJJmeG:{dHXyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iUHXyc5hqe2:vZTDwdo9tcW[ncnH0c5Ih[WO2aY\heIVlKHKnY3XweI9zKGejbX3hJGdidDRiY3jpcYVzcWNiaX6geJJidnOrZX70cJkhfHKjboPm[YN1\WRiQ2[tNUBk\WyuczDifUBnfW6ldHnvcoFtKGG|c3H5MEBGSzVyPUCuNFQ{KM7:TR?= MYSxNVczODh3NB?=
COS-1 cells MWnGeY5kfGmxbjDhd5NigQ>? M2L3TmlvKH[rdILvJJRz[W6|YXP0bZZifGmxbjDv[kBpfW2jbjDw[ZJwgGm|b33lJJBzd2yrZnXyZZRweiCjY4TpeoF1\WRicnXj[ZB1d3JiZ3HtcYEhdWWjc4Xy[YQhcW5iUGDBVk1ISUx2IHPobY1memmlIFPPV{0yKGOnbHzzMEBGSzVyPUCuNFIh|ryP NUTpdJVOOTJ6N{O1NVc>
CV-1 cells Mo\ESpVv[3Srb36gZZN{[Xl? NEXJcmxC[3SrdnH0bY9vKG:oIIDldo95cXOxbXWgdJJwdGmoZYLheI9zKGGldHn2ZZRm\CC{ZXPldJRweiCpYX3tZUBu\WG|dYLl[EBjgSCrbnT1Z5Rqd25ib3[gOVAmKG:oIH3hfIlufW1iYXzrZYxqdmVicHjvd5Bp[XSjc3WgZYN1cX[rdImsJJRz[W6|ZnXjeIlwdiCjc4PhfUBqdiCFVj2xJINmdGy|LDDFR|UxRTBwMEi5NVMh|ryP NGfKWYk6QDN4NkKw
CV-1 cells NYjhcWtZTnWwY4Tpc44h[XO|YYm= NXvONpNjUW5idnn0do8hfHKjboPjdolxfGmxbnHsJIFkfGm4YYTpc44hd2ZiUHXyc5hqe2:vZTDwdo9tcW[ncnH0c5Ih[WO2aY\heIVlKHKnY3XweI9zKGejbX3hJEhRWEGUKTDlfJBz\XO|ZXSgbY4hS1ZvMTDj[YxteyxiRVO1NF0xNjB4IN88US=> MUS4OVc3QTB5
COS-1 cells NXrFd3FUTnWwY4Tpc44h[XO|YYm= MV7JckB3cXS{bzDh[49vcXO2IHHjeIl3cXS7IITld5Rm\CCob4KgeJJidnOjY4TpeoF1cW:wIHnuJIh2dWGwIGDQRXIh\2GvbXGtS4FtPCClaHnt[ZJq[yCFT2OtNUBk\WyuczygSWM2OD1yLkCyJO69VQ>? NWTVZ3Y4OTJ5Mkm2Olg>
CV-1 cells MmDYSpVv[3Srb36gZZN{[Xl? MUjJckB3cXS{bzDleoFtfWG2aX;uJIFo[Wmwc4SgVnhTNWGucHjhM3BRSVJvZ3HtcYEhcW5iQ2[tNUBk\WyuczDifUBkd3S{YX7z[oVkfGmxbjDhd5NigSC5YYOg[IV1\XKvaX7l[EwhTUN3ME2wMlMzPSEQvF2= NWHyc4YxOTJ7NUSwOlE>
HepG2 cells NWTURVhXTnWwY4Tpc44h[XO|YYm= MmO5SYZn\WO2aY\lJINwdmOnboTyZZRqd25iYXfhbY5{fCCqdX3hckBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFjldGczKGOnbHzzMEBGSzVyPUCuNFM6KM7:TR?= NGfMUGgyPjFyN{G1NC=>
Huh7 cells MVvGeY5kfGmxbjDhd5NigQ>? MUPGeY5kfGmxbnHsJIFkfGm4aYT5JIF1KGi3bXHuJHBRSVJiZ3HtcYEhcW5iSIXoO{Bk\WyuczDifUB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5{MjFOwG0> MXmxOlM3PjZyMR?=
Huh7 cells NYTIOlVQTnWwY4Tpc44h[XO|YYm= M3\1OGVn\mWldDDvckBRWEGUIHfhcY1iKHS{YX7zZYN1cX[jdHnvckBi[3Srdnn0fUBqdiCKdXi3JINmdGy|LDDFR|UxRTBwMkKg{txO M4HwN|E3PDVzMEi3
U2OS cells NXrnSYJGTnWwY4Tpc44h[XO|YYm= NUeySI9ZTW[oZXP0JI9vKFCSQWLnZY1u[SC2cnHud4FkfGm4YYTpc44h[WO2aY\peJkhcW5iVULPV{Bk\WyuczygSWM2OD1yLkCzJO69VQ>? NEnRZ5MyPjNyMEm0OC=>
CV1 cells M3jiOGZ2dmO2aX;uJIF{e2G7 MoLaWJJidnOjY4TpeoF1cW:wIH;mJHBRSVKpYX3tZUBqdiCFVkGgZ4VtdHNuIFXDOVA:OC5yN{[g{txO M{fTUlE3QDJzN{[5
human keratinocytes NVLzTFEyWHKxbHnm[ZJifGmxbjDhd5NigQ>? NULOVFk5SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDr[ZJifGmwb3P5eIV{NCCHQ{WwQVgh|ryP M{juelE3QDJzN{[5
HT29 cell NVXkc5lVWHKxbHnm[ZJifGmxbjDhd5NigQ>? MUfBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEiWMkmgZ4VtdCCuaX7lMEBGSzVyPUS1JO69VQ>? MoHwNVY5OjF5Nkm=
NIH3T3 cells MUDGeY5kfGmxbjDhd5NigQ>? M4L6XGFkfGm4aYT5JIF1KGi3bXHuJHBRSVJiZ3HtcYEhfHKjboPm[YN1\WRiaX6gUmlJO1R|IHPlcIx{KGK7IHz1Z4ln\XKjc3WgZYN1cX[rdImgZZN{[XluIFXDOVA:OC5|MjFOwG0> MnOzNVY5PTRyOEW=
CV1 cells M3L0WWZ2dmO2aX;uJIF{e2G7 NInW[25VemGwc3HjeIl3[XSrb36gc4YhcHWvYX6gVHBCWmejbX3hJIlvKEOYMTDj[YxteyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE4{ODhizszN NX[zcJl5OTZ7N{CzPVE>
Huh7 cells NF3ScG5HfW6ldHnvckBie3OjeR?= NGXpfY1C[3Srdnn0fUBifCCqdX3hckBRWEGUIHfhcY1iKGmwIFj1bFch[2WubIOgZpkhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTBwMkKg{txO M3\jdVE4ODN2MUS5
HepG2 cells Mn3SSpVv[3Srb36gZZN{[Xl? MUPB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXIh\2GvbXGgbY4h[SCKZYDHNkBk\WyuczDifUBRWEGULVfBUFQhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTBwMUW4JO69VQ>? MV:xOlk4OzN3OB?=
HepG2 cells MYLGeY5kfGmxbjDhd5NigQ>? Mo\BRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFTKGejbX3hJIlvKEincFeyJINmdGy|IHL5JHBRSVJvR1HMOEB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5zNUlOwG0> M2i5WlE3QTd7M{Sx
CV1 cells NVv0OFM4TnWwY4Tpc44h[XO|YYm= NGT5RnNC[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEhcW5iQ2[xJINmdGy|LDDFR|UxRTBwM{C4JO69VQ>? NXjKco9zOTdyMEWzPVQ>
HEK293 cells NFHQdndHfW6ldHnvckBie3OjeR?= MXvBZ5Rqfmm2eTDheEBpfW2jbjDh[Ilxd3OnIITpd5N2\SCSUFHSJIdidW2jIHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNiYomgVHBCWi2JQVy0JJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjNzIN88US=> NFHwT28yPzN2M{O3NS=>
rat L6 cells MYfGeY5kfGmxbjDhd5NigQ>? MVXF[oZm[3Rib36g[oF1fHliYXPp[EBwgGmmYYTpc44hcW5icnH0JGw3KGOnbHzzMEBGSzVyPUWg{txO NETBWocyPzN2M{O3NS=>
HepG2 cells MmTUSpVv[3Srb36gZZN{[Xl? Mo\aRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT\2GvbXGgbY4hUGWyR{KgZ4VtdHNiYomgVHBCWi2JQVy0JJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjB6MjFOwG0> NUWyU3VVOTdzNUewNVk>
CV1 cells NGC5VGFHfW6ldHnvckBie3OjeR?= NH3mT3BC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKjbIDoZUBqdiCFVkGgZ4VtdHNiYomgS2FNPCC2cnHud4FkfGm4YYTpc44h[XO|YYmgZYZ1\XJiMkSgbJJ{NCCHQ{WwQVMvPDZizszN MWixO|UxPzJ{NR?=
CV1 cells MXPGeY5kfGmxbjDhd5NigQ>? NHTPUFJC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBqdiCFVkGgZ4VtdHNiYomgS2FNPCC2cnHud4FkfGm4YYTpc44h[XO|YYmgZYZ1\XJiMkSgbJJ{NCCHQ{WwQVAvODNizszN NImyR5cyPzVyN{KyOS=>
CV1 cells M3TCemZ2dmO2aX;uJIF{e2G7 MXvB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDlfJBz\XO|ZXSgbY4hS1ZzIHPlcIx{KGK7IILlZ4VxfG:{IITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlMxQCEQvF2= M1jadVE5ODJ7MUe4
CV1 cells Mnm1SpVv[3Srb36gZZN{[Xl? MWTB[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUBqdiCFVkGgZ4VtdHNiYomgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvOzB6IN88US=> NES2ZmUyPzF{OUeyOS=>
HEK293 cells NGPFUIFHfW6ldHnvckBie3OjeR?= M4X5[2Fod26rc4SgZYN1cX[rdImgZZQhWFCDUnfhcY1iKHKnY3XweI9zKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[nliR1HMOEB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5yM{Wg{txO NYjSdnlHOTd{OUK2NFY>
NIH3T3 cells MUfGeY5kfGmxbjDhd5NigQ>? M17BPGFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIV5eHKnc4Pl[EBqdiCQSVizWFMh[2WubIOgZpkhT0GONDD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9NE4{OiEQvF2= MWKxO|YzPDd5Nx?=
HEK293 cells MYDGeY5kfGmxbjDhd5NigQ>? NHflWmxC\2:waYP0JIFkfGm4aYT5JIF1KFCSQWLnZY1u[SCneIDy[ZN{\WRiaX6gTGVMOjl|IHPlcIx{KGK7IFfBUFQhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTBwMUmg{txO M2LOclE5ODJ7MUe2
HEK293 cells NXnFfIM4TnWwY4Tpc44h[XO|YYm= NU\U[4lUSWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCjc4Pld5Nm\CCjczDhVFIh\2WwZTDpcoR2[3Srb36sJGVEPTB;MD6xNkDPxE1? NVntS|d5OThyMkmxO|Y>
HEK293 cells NGezcmVHfW6ldHnvckBie3OjeR?= M4X1O2Fod26rc4SgZYN1cX[rdImgZZQhWFCDUnfhcY1iKGmwIFjFT|I6OyClZXzsd{BjgSCJQVy0JJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjB2NTFOwG0> NYH4TGNtOTh{OUG2OFU>
HepG2 cells MVLGeY5kfGmxbjDhd5NigQ>? M1XxVWFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmGucHjhJIxq\2GwZDDibY5lcW6pIHTvcYFqdiCneIDy[ZN{\WRiaX6gbJVu[W5iSHXwS|Ih[2WubIOgZ48ufHKjboPm[YN1\WRid3n0bEBI[Wx2IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiRVO1NF0xNjB|OTFOwG0> MnH0NVg5OzV5MUm=
RAW264.7 cells NH3idZVHfW6ldHnvckBie3OjeR?= MoTnV5VxeHKnc4Ppc44hd2ZiTGDTM2lHVi2pYX3tZU1{fGmvdXzheIVlKE6RIIDyc4R2[3Srb36gbY4hdW:3c3WgVmFYOjZ2LkegZ4VtdHNuIFXDOVA:OTdwNTFOwG0> NIqxUYUyQDhyOUOyOS=>
BL21 cells M1i4[WZ2dmO2aX;uJIF{e2G7 NHjvZodFcXOybHHj[Y1mdnRib3[gdoFlcW9ibHHi[Yxm\CB{KGOpMUgzNWKnborvfYwueGinbonsZY1qdm9rLUOtf|QuYzFuMT3kbZRzcXSrbz2yMUg2NW2ndHj5cE0zNXCqZX75cE1wgGG8b3ytOE16dClvZYToc5h6ZS2yaHXufYx:NXC{b4Dpc45q[yCjY3nkJIZzd21iR2PUMYZ2e2WmIHj1cYFvKFCSQWLnZY1u[SCneIDy[ZN{\WRiaX6gSZNkcGW{aXPobYEh[2:uaTDCUFIyKGOnbHzzJIJ6KHOlaX70bYxt[XSrb36gdJJwgGmvaYT5JIF{e2G7LDDFR|UxRTBwNEWg{txO NVe1dJk1OTl|NEmxO|Y>
BHK21 cells NF;Hb41HfW6ldHnvckBie3OjeR?= M3TjR2Fod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIV5eHKnc4Pl[EBqdiCESFuyNUBk\WyuczDhd5Nme3OnZDDhd{BUTUGSIHHjeIl3cXS7IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTBwNEWg{txO MUCxPVM1QTF5Nh?=
HepG2/C3A cells MnvlSpVv[3Srb36gZZN{[Xl? MXPBZ5RqfmG2aX;uJI9nKGi3bXHuJHBRSVKpYX3tZUBtcWejbnSgZolv\GmwZzDkc41icW5vbXXkbYF1\WRidILhcpNkemmydHnvcoFtKGGldHn2bZR6KGmwIHj1cYFvKEincFeyM2M{SSClZXzsd{Bkdy22cnHud4Zm[3SnZDD3bZRpKG[3c3XkJGdidDRvTFLEJIJ6KGOxdILhcpNn\WO2aX;uJIF{e2G7LDDFR|UxRTBwMECzPEDPxE1? MY[xO|QxOzZ6OB?=
HepG2 cells NVi5RmlxTnWwY4Tpc44h[XO|YYm= NIfQUFFC\2:waYP0JIFkfGm4aYT5JIF1KFCSQWLnZY1u[SCneIDy[ZN{\WRiaX6gbJVu[W5iSHXwS|Ih[2WubIOgZZN{\XO|ZXSgZZMhcW6mdXP0bY9vKG:oIILlZ4VxfG:{IITyZY5{[WO2aY\heIlwdiCkeTDy[ZBwenSncjDn[Y5mKGG|c3H5JJJmdGG2aY\lJJRwKGOxboTyc4wtKEWFNUC9NE4xPSEQvF2= MljUNVg3OjV3NUm=
COS1 cells NYPh[GM5TnWwY4Tpc44h[XO|YYm= MmHjRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDy[YNwdWKrbnHueEBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFPPV|Eh[2WubIOgZ48u\XiycnXzd4lv\yCJQVy0JIF{e2W|c3XkJIF{KHS{YX7zZ5JqeHSrb37hcEBi[3Srdnn0fUBi\nSncjC0PEBpenNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwQVAvODJizszN MmHONVk2ODd6NkG=
HepG2 cells M{\x[GZ2dmO2aX;uJIF{e2G7 M2raWGFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIV5eHKnc4Pl[EBqdiCKZYDHNkBk\WyuczDifUBISUx2IITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlIzOyEQvF2= M4fyU|E5Ozl2OUC3
CV1 cells NILBcGZHfW6ldHnvckBie3OjeR?= NIjaSHFC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBtcWejbnSgZolv\GmwZzDkc41icW5iZYjwdoV{e2WmIHnuJIFnemmlYX6g[5Jm\W5ibX;ub4V6KEOYMTDj[YxteyClbz30doFve2[nY4Tl[EB4cXSqIH\1d4VlKEejbEStSGJFKGK7IITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlA{OyEQvF2= Mnm2NVg5OjZ{MEW=
CV1 cells M4DtdWZ2dmO2aX;uJIF{e2G7 MX7B[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJidHCqYTDsbYdidmRiYnnu[Ilv\yCmb33hbY4h\XiycnXzd4VlKGmwIHHmdolk[W5iZ4Ll[Y4hdW:wa3X5JGNXOSClZXzsd{Bkdy22cnHud4Zm[3SnZDD3bZRpKG[3c3XkJGdidDRvRFLEJIJ6KHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1|LkS2JO69VQ>? MnrXNVg5OjZ{MEW=
U2OS cells NW\UZ4hPTnWwY4Tpc44h[XO|YYm= NVz0bpBzSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEhcW5iVULPV{Bk\WyuczDifUB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5yMjFOwG0> Ml;sNVg{Ojl5NUG=
Hep G2 cells NX6yRZBrTnWwY4Tpc44h[XO|YYm= NUPjNXl1SWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEhdGmpYX7kJIJqdmSrbneg[I9u[WmwIHX4dJJme3OnZDDpckBpfW2jbjDI[ZAhTzJiY3XscJMh[29vdILhcpNn\WO2ZXSge4l1cCCJYXy0MWRDTCCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE4xPCEQvF2= MVWxPVA2Ozd5Nh?=
HeLa cells MUfGeY5kfGmxbjDhd5NigQ>? MoHzRYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEhdGmpYX7kJIJqdmSrbneg[I9u[WmwIHX4dJJme3OnZDDpckBpfW2jbjDI[WxiKGOnbHzzJINwNXS{YX7z[oVkfGWmIIfpeIghT2GuND3ERmQh[XO|ZYPz[YQh[XNidILhcpNkemmydHnvcoFtKGGldHn2ZZRqd25iYomgS4FtPCC{ZYPwc45{\SCnbHXt[Y51NWS{aY\lckBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVA:OC5yMUWg{txO MVWxPVI4PTl4Mx?=
COS1 cells M{XpU2Z2dmO2aX;uJIF{e2G7 NUnTdXVGSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEhemWlZYD0c5Ih\XiycnXzd4VlKGmwIHHmdolk[W5iZ4Ll[Y4hdW:wa3X5JGNQWzFiY3XscJMh[29vdILhcpNn\WO2ZXSge4l1cCCodYPl[EB6\WG|dDDHZYw1NUSERDDifUB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5yMjFOwG0> MljkNVk2OzB4OEG=
U2OS cells M{PvTGZ2dmO2aX;uJIF{e2G7 NHX0R41C\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iVULPV{Bk\WyuczDifUBtfWOrZnXyZZNmKHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkC1JO69VQ>? MUCxPVU4PDB3Nh?=
HepG2 cells NFPqbYVHfW6ldHnvckBie3OjeR?= NH3r[HFC\2:waYP0JIFkfGm4aYT5JIF1KEeDTESteIFo\2WmIHj1cYFvKFCSQWLnZY1u[SCuaXfhcoQh[mmwZHnu[{Bld22jaX6g[ZhxemW|c3XkJIlvKGi3bXHuJGhmeEd{IHPlcIx{KGG|c3Xzd4VlKGG|IILlZ4VxfG:{IITyZY5{[WO2aY\heIlwdiCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE4xOzlizszN MWGxPVc4PTF4OR?=
HepG2 cells MXXGeY5kfGmxbjDhd5NigQ>? NUXjd5lLSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFjldGczKGOnbHzzJIJ6KEeDTESgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvOjJ|IN88US=> MmfJNVk4QDN2NES=
COS7 cells NGHVPHlHfW6ldHnvckBie3OjeR?= NXPTW3B7SWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBz\WOxbXLpcoFvfCCSUFHS[4FudWF{IFzCSEBmgHC{ZYPz[YQhcW5iYX\ybYNidiCpcnXlckBud26tZYmgR29UPyClZXzsd{Bkd2W6cILld5NqdmdiR1HMOEBjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTBwMTFOwG0> MoLuNlAyOzh5NkK=
COS7 cells MkLESpVv[3Srb36gZZN{[Xl? MWrB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIILlZ49u[mmwYX70JHBRSVKpYX3tZVEhVEKGIHX4dJJme3OnZDDpckBi\nKrY3HuJIdz\WWwIH3vcotmgSCFT2O3JINmdGy|IHPv[ZhxemW|c3nu[{BISUx2IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9NE4xOyEQvF2= NVfHbZdoOjBzM{i3OlI>
HEK cells MmDSSpVv[3Srb36gZZN{[Xl? MlHIRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDHRWw1NXSjZ3fl[EBRWEGUYXzwbIEh[2irbXXybYMhemWlZYD0c5Ih\XiycnXzd4VlKGmwIFjFT{Bk\WyuczDifUB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OTBwNUig{txO NV;LelNzOjB{OUmyNVQ>
HEK cells MWHGeY5kfGmxbjDhd5NigQ>? M{LBb2Fod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gS2FNPC22YXfn[YQhWFCDUnfhcY1iKGOqaX3ldolkKHKnY3XweI9zKGW6cILld5Nm\CCrbjDISWsh[2WubIOgZpkhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTBwMEO1JO69VQ>? NYTFWJpEOjB{OUmyNVQ>
3T3L1 cells M1fsXWZ2dmO2aX;uJIF{e2G7 MXS3JIRigXN? MV;JcoR2[3Srb36gc4Yh[WSrcH;n[Y5me2m|IHnuJI1wfXOnIEPUN2wyKGOnbHzzJIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIHzpdIllKGGlY4XteYxifGmxbjDh[pRmeiB5IHThfZMh[nliT3nsJJJm\CCRIIP0ZYlvcW6p M{foN|IxPTJ5OU[5
CHO-K1 cells MlfiSpVv[3Srb36gZZN{[Xl? MUXQZZJ1cWGuIHHnc45qe3RiYXP0bZZqfHliYYSgbJVu[W5iUGDBVodidW2jLVzCSEBmgHC{ZYPz[YQhcW5iQ1jPMWsyKGOnbHzzJINwNXS{YX7z[oVkfGWmIIfpeIghT0GONDDhd5Nme3OnZDDhd{BtfWOrZnXyZZNmKGGldHn2bZR6KGK7IITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlEh|ryP NHLLXGozODV{N{m2PS=>
HEK293T cells MnvkSpVv[3Srb36gZZN{[Xl? NI\scHAyKM7:TR?= Mkn4NlQhcHK| NYPUXGVYWGG{dHnhcEBi\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZU1NSkRiZYjwdoV{e2WmIHnuJGhGUzJ7M2SgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5lfWO2aX;uJI9nKHKnY3XweI9zKHS{YX7zZYN1cX[jdHnvckBifCBzIIXNJIFnfGW{IEK0JIhzeyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZk> NYLQUpNUOjFyM{CyOlM>
CV1 cells Mmq2SpVv[3Srb36gZZN{[Xl? MXXUdoFve2GldHn2ZZRqd25ib3[gS4FtPC2odYPl[EBpfW2jbjDQVGFT\2GvbXGgSG5CKGKrbnTpcoch\G:vYXnuJIV5eHKnc4Pl[EBqdiCjZoLpZ4FvKGe{ZXXuJI1wdmuneTDDWlEh[2WubIOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxRTBwMTFOwG0> M13zW|IyOTF{N{i0
HEK293 cells Ml\qSpVv[3Srb36gZZN{[Xl? MUmxOkB1dyB{MDDodpM> NHyyPHZVemGwc3HjeIl3[XSrb36gc4YhT2GuND3meZNm\CCqdX3hckBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{Bi\nSncjCxOkB1dyB{MDDodpMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyPUCuNFQ{KM7:TR?= NX:xRWZXOjFzMki2NFA>
HepG2 cells NHfRcW1HfW6ldHnvckBie3OjeR?= MmTRNVAhfW2xbD;M NUfUTWdjOjRiaILz NXnNbVZNUW6lcnXhd4UhcW5iZ3z1Z49{\SClb37zeY1xfGmxbjDpckBpfW2jbjDI[ZBIOiClZXzsd{BifCBzMDD1cY9tN0xiYX\0[ZIhOjRiaILzJJJmdGG2aY\lJJRwKGOxboTyc4w> MWqyNVI2Pjd2OB?=
3T3L1 cell MWnGeY5kfGmxbjDhd5NigQ>? Mk\KNUB2VQ>? NHjDcHNKdmS3Y4Tpc44hd2ZibX;1d4UhO1R|TEGgZ4VtdCCmaX\m[ZJmdnSrYYTpc44h[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gZYNkfW23bHH0bY9vKG:oIHnueJJi[2WubIXsZZIhdGmyaXSg[JJweGyndDDheEAyKHWPIHL5JG9qdCC{ZXSgU{B{fGGrbnnu[y=> M4DPcFIyPDBzMUG4
CV1 cells NFrxXGJHfW6ldHnvckBie3OjeR?= NG\QWJE1OCCq NVzXVYZvSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEuVEKGIHX4dJJme3OnZDDpckBEXjFiY3XscJMh[29vdILhcpNn\WO2ZXSge4l1cCCJYXy0JIFnfGW{IESwJIhzeyCkeTDseYNq\mW{YYPlJIJie2WmIITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlEh|ryP M3TLeVIyPTF3ME[z
HepG2 cells NGTjVGJHfW6ldHnvckBie3OjeR?= MUTB[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUBz\WOncITvdkBmgHC{ZYPz[YQhcW5iaIXtZY4hUGWyR{KgZ4VtdHNiYomgVHBTTS2udXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTB;MD6wNUDPxE1? NV7FdFBQOjF2OEK0OFY>
HepG2 cells NYKwZXhFTnWwY4Tpc44h[XO|YYm= MlW2WJJidnOjY4TpeoF1cW:wIH;mJIh2dWGwIGDQRXJo[W2vYTDlfJBz\XO|ZXSgbY4hcHWvYX6gTIVxTzJiY3XscJMh[29vdILhcpNn\WO2ZXSge4l1cCCSUGLFN{1VUy2OdXOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxRTBwMEWg{txO M{fMZVIyPDVyNE[4
COS7 cells NU\XfmZETnWwY4Tpc44h[XO|YYm= M3nyb21w\HWuYYTpc44hd2ZiaIXtZY4hWFCDUnfhcY1iNUyERDDlfJBz\XO|ZXSgbY4h[W[{aXPhckBoemWnbjDtc45s\XliQ1;TO{Bk\WyuczDjc{11emGwc3\lZ5Rm\CC5aYToJGdidDRiYYPz[ZN{\WRiYYOgZYN1cX[jdHnvckBw\iC2cnHud4FkfGm4YYTpc44h[WO2aY\peJkh[nlibIXjbYZmemG|ZTDhd5NigSxiRVO1NF0xNjB2MzFOwG0> M2jXXlIyQDd|MEew
COS-1 cells M1PkTmZ2dmO2aX;uJIF{e2G7 NIPP[3AzPCCqcoO= NIHiTW9C\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBtcWejbnSgZolv\GmwZzDkc41icW5iZYjwdoV{e2WmIHnuJGNQWy1zIHPlcIx{KGGodHXyJFI1KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWtZoF{\WRibIXtbY5wdWW2cnnjJIFv[Wy7c3nzMEBGSzVyPUCuNFQ5KM7:TR?= NUTOTG1pOjJyNUGwOVQ>
COS1 cells M1jpUmZ2dmO2aX;uJIF{e2G7 NEfjTHIzPCCqcoO= MnnCWJJidnOjY4TpeoF1cW:wIH;mJIh2dWGwIH\1cIwhdGWwZ4ToJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iQ1;TNUBk\WyuczDjc{11emGwc3\lZ5Rm\CC5aYToJHJZWmGucHjhJIFnfGW{IEK0JIhzeyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE4yOiEQvF2= Ml\yNlIyQTd|OU[=
MG-63 cells M3u5NGZ2dmO2aX;uJIF{e2G7 NWDpR4MzSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIF3HMVY{KGOnbHzzJIJ6KHKncH;yeIVzKGenbnWtZoF{\WRidILhcpNi[3SrdnH0bY9vKGG|c3H5MEBGSzVyPUCuNFEyKM7:TR?= MoPvNlIzOjV4NEG=
COS1 cells MUfGeY5kfGmxbjDhd5NigQ>? MoD3Rolv\GmwZzDh[oZqdmm2eTD0c{BpfW2jbjD3bYxlKHS7cHWgVHBCWmejbX3hJGxDTCCneIDy[ZN{\WRiaX6gR29UOSClZXzsd{Bkdy2neIDy[ZN{cW6pIFfBUFQh[nlic3PpcpRqdGyjdHnvckBxem:6aX3peJkh[XO|YYm= NGKwelczOjB5ME[wOC=>
MG-63 cells MWHGeY5kfGmxbjDhd5NigQ>? M3LyRlI1KGi{cx?= M{DteW1w\HWuYYTpc44hd2ZiZoXscE1t\W6pdHigbJVu[W5icGPHOU1nfXOnZDDQVGFT\2GvbXGg[ZhxemW|c3XkJIlvKE2JLU[zJINmdGy|IHPvMYV5eHKnc4PpcocheEeYLWCyMXBRWkViYX\0[ZIhOjRiaILzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBj[XOnZDD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9NE4xOTFizszN NUThcG9XOjJ5Mke0OFg>
Ac2F cells M3nDW2Z2dmO2aX;uJIF{e2G7 MXSwMlEhfG9iMUCg{txO NEGyPJQ3KGi{cx?= M3HxPWFod26rc4SgZYN1cX[rdImgZZQhWFCDUnfhcY1iKGmwIILheEBC[zKIIHPlcIx{KGG|c3Xzd4VlKGG|IHz1Z4ln\XKjc3WgZYN1cX[rdImgZZQhOC5zIITvJFExKHWPIHHmeIVzKDZiaILzJIJ6KHKncH;yeIVzKGenbnWgZZN{[Xl? NIfDT4gzOjhzOUG5NC=>
293H DA cells M2jyOGZ2dmO2aX;uJIF{e2G7 M4\M[VE3KGh? NGLDU5pC\2:waYP0JIFkfGm4aYT5JIF1KFCSQWLnZY1u[SCOQlSgbY4hcHWvYX6gNlk{UCCGQTDj[YxteyCjZoTldkAyPiCqcoOgZpkhXFJvRmLFWEBi[3SrdnH0bY9vKHKncH;yeIVzKGG|c3H5MEBGSzVyPUCuNFAzPCEQvF2= MVyyNlU5Ojl5Mx?=
3T3L1 cells M{jVe2Z2dmO2aX;uJIF{e2G7 M3TPc|ExKHWP NITCb45KdmO{ZXHz[UBqdiCjZHnwc45m[3SrbjDtVm5CKGyndnXsd{BqdiCWTl\hcJBp[S2rbnT1Z4VlKG2xdYPlJFNVO0xzIHPlcIx{KHC{ZYTy[YF1\WRiYYSgNVAhfU1iYnXmc5JmKFSQRj3hcJBp[SClaHHscIVv\2VicnXsZZRqfmVidH:gZ49vfHKxbB?= NYfCPXFYOjF6NUGwPFk>
HepG2 cells NIW1eIpHfW6ldHnvckBie3OjeR?= NXvWdo53OTBidV2= MXKyOEBp NET1bpVT\WS3Y4Tpc44hd2ZiZ3z1Z49{\SClb37zeY1xfGmxbjDpckBqdnO3bHnuMZJme2m|dHHueEBpfW2jbjDI[ZBIOiClZXzsd{BifCBzMDD1UUBi\nSncjCyOEBpenNiYomg[4x2[2:|ZTDvfIll[XOnIH3leIhw\CCrbjDwdoV{\W6lZTDv[kAzOi5{IH3NJI9nKGeudXPvd4U> NG\DPJQzOzB{NUK0OC=>
HepG2 cells NEG4XZhHfW6ldHnvckBie3OjeR?= NXj1dI9oOTBidV2= MX:yOEBp MlTaVoVlfWO2aX;uJI9nKGeudXPvd4Uh[2:wc4XtdJRqd25iaX6gbY5{fWyrbj3y[ZNqe3SjboSgbJVu[W5iSHXwS|Ih[2WubIOgZZQhOTBidV2gZYZ1\XJiMkSgbJJ{KGK7IHfseYNwe2Vib4jp[IF{\SCvZYToc4QhcW5icILld4Vv[2Vib3[gNE4yKHWPIH;mJIlve3WuaX6= M1zoNFI{ODJ3MkS0
THP1 cells NEj3WZZHfW6ldHnvckBie3OjeR?= NVTndWt{OTByIIXN M3;ublMhcHK| NXnU[W1wXHKjboPhZ5RqfmG2aX;uJI9nKFCSQWLnZY1u[SCrbjDoeY1idiCWSGCxJINmdGy|IHHzd4V{e2WmIHHzJIRm[3KnYYPlJIlvKEySUz3pcoR2[2WmIF3DVFEhdVKQQTDlfJBz\XO|aX;uJIF1KDFyMDD1UUBxemWrbnP1ZoF1\WRiZn;yJFMhcHK|IIDybY9zKHSxIFzQV{BkcGGubHXu[4UhdWWjc4Xy[YQh[W[2ZYKgNVghcHK|IHL5JHJVNVCFUjDhcoFtgXOrczDy[YxifGm4ZTD0c{B2dnS{ZXH0[YQh[2:wdILvcC=> NYDpV4xJOjJ7M{S1N|c>
THP1 cells M3TwWGZ2dmO2aX;uJIF{e2G7 MVexNFAhfU1? MkLmN{BpenN? MVrUdoFve2GldHn2ZZRqd25ib3[gVHBCWmejbX3hJIlvKGi3bXHuJHRJWDFiY3XscJMh[XO|ZYPz[YQh[XNiZHXjdoVie2ViaX6gUHBUNWmwZIXj[YQhUUx4IH3SUmEh\XiycnXzd4lwdiCjdDCxNFAhfU1icILlbY5kfWKjdHXkJIZweiB|IHjyd{BxemmxcjD0c{BNWFNiY3jhcIxmdmenIH3lZZN2emWmIHHmeIVzKDF6IHjyd{BjgSCUVD3QR3Ih[W6jbInzbZMhemWuYYTpeoUhfG9idX70doVifGWmIHPvcpRzd2x? MUOyNlk{PDV|Nx?=
HepG2 cells M3TNemZ2dmO2aX;uJIF{e2G7 Moi3WJJidnOjY4TpeoF1cW:wIH;mJGdCVDRvZoXz[YQhWFCDUnfhcY1iKGyrZ3Hu[EBjcW6maX7nJIRwdWGrbjD0doFve2[nY4Tl[EBqdiCqdX3hckBJ\XCJMjDj[YxteyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE4yKM7:TR?= NV;GZpBjOjJ7M{S1N|c>
HepG2 cells MXLGeY5kfGmxbjDhd5NigQ>? NFvjdWwzOCCq MonORYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDHRWw1NW[3c3XkJHBRSVKpYX3tZUBtcWejbnSgZolv\GmwZzDkc41icW5iZYjwdoV{e2WmIHnuJGhmeEd{IHPlcIx{KGGodHXyJFIxKGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvODJizszN MWiyNlA5OTl|Mh?=
BL21 DE3 cells NWXVS5J6TnWwY4Tpc44h[XO|YYm= NV\nb5h3TGm|cHzhZ4Vu\W62IH;mJHs{UF2{b4Pp[4xqfGG8b37lJIZzd21iTj30[ZJucW6jbDDIbZMufGGpZ3XkJIh2dWGwIGDQRXJo[W2vYTDsbYdidmRiYnnu[Ilv\yCmb33hbY4h\XiycnXzd4VlKGmwIFXzZ4hmemmlaHnhJINwdGliQlyyNUBFTTNiY3XscJMh[nlic3PpcpRqdGyjdHnvckBxem:6aX3peJkh[XO|YYmsJGtqRTBwMEe0JO69VQ>? NXywXFJVOjJyOEG5N|I>
human L02 cells NX22OXJ6TnWwY4Tpc44h[XO|YYm= NEDobZBC\2:waYP0JIFkfGm4aYT5JIF1KFCSQWLnZY1u[S2OQlSg[ZhxemW|c3XkJIlvKGi3bXHuJGwxOiClZXzsd{Bkdy2neIDy[ZN{cW6pIIDHUFMuW1Z2MD3HRWw1KGGodHXyJFI1KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZoF{\WRidILhcpNi[3SrdnH0bY9vKGG|c3H5MEBGSzVyPUCuPUDPxE1? MnWzNlMyQDZ|MEe=
HepG2 cells MXnGeY5kfGmxbjDhd5NigQ>? NEDRTFczOCCq NYjGVlVpXHKjboPhZ5RqfmG2aX;uJI9nKEeDTESt[pV{\WRiaIXtZY4hWFCDUnfhcY1iKGyrZ3Hu[EBjcW6maX7nJIRwdWGrbjDlfJBz\XO|ZXSgbY4hUGWyR{KgZ4VtdHNiYX\0[ZIhOjBiaILzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OD1yLkCzPUDPxE1? NEfzOWczOzF5MUC0OS=>
HEK293 cells NEfWc4NHfW6ldHnvckBie3OjeR?= NXvwflVnOTBizszN MWLUdoFve2GldHn2ZZRqd25ib3[gVHBCWmejbX3hJEh2dmuwb4fuJI9zcWerbjmg[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczDjc{11emGwc3\lZ5Rm\CC5aYToJGFROi2SUGLFJIF1KDFyIIXNJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeR?= MWmyN|I4OzVzOR?=
HEK293 cells NXHhZ5VUTnWwY4Tpc44h[XO|YYm= MWfB[49vcXO2IHH0JIh2dWGwIGDQRXJo[W2vYTDMRmQh\XiycnXzd4VlKGmwIHj1cYFvKEiHS{K5N{Bk\WyuczDjc5Rz[W6|ZnXjeIVlKHerdHigS2FNPC2OdXOgZZN{\XO|ZXSgZZMhfHKjboPjdolxfGmxbnHsJIFkfGm4YYTpc44h[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyPUCuNFA1KM7:TR?= NH3GNm4zOzJ6Nke4Oy=>
HEK293 cells M3nHU2Z2dmO2aX;uJIF{e2G7 MXyyOEBp MnXvWJJidnOjY4TpeoF1cW:wIH;mJGdCVDRiRFLEMYZ2e2WmIHj1cYFvKFCSQWLnZY1u[S2OQlSg[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczDh[pRmeiB{NDDodpMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyPUCuNUDPxE1? MY[yN|I6PDh|MB?=
HEK293 cells MYrGeY5kfGmxbjDhd5NigQ>? NWi1[IxtPDhiaILz NIryXYpC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJINwfHKjboPm[YN1\WRid3n0bEBRWFKHeEStWGsudHWlIHHzd4V{e2WmIHHzJIFkfGm4YYTpc44hd2ZibIXjbYZmemG|ZTDhZ5Rqfmm2eTDt[YF{fXKnZDDh[pRmeiB2ODDodpMh[nlidILhcpNi[3SrdnH0bY9vKGG|c3H5MEBGSzVyPUSzMlcyKM7:TR?= MWOyN|I3PTh2NB?=
HepG2 cells Ml7GSpVv[3Srb36gZZN{[Xl? Mn6xRYdwdmm|dDDhZ5Rqfmm2eTDheEBISUx2LX\1d4VlKFCSQWLnZY1u[SBqdX7rco94diCxcnnnbY4qKGW6cILld5Nm\CCrbjDoeY1idiCKZYDHNkBk\WyuczDifUB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5yMTFOwG0> MUWyN|UxOjJzMh?=
HepG2 cells MoPuSpVv[3Srb36gZZN{[Xl? NFrKTGpC\2:waYP0JIFkfGm4aYT5JIF1KEeDTESt[pV{\WRiUGDBVodidW2jIF20OlNCKG23dHHueEApfW6tbn;3ckBwemmpaX6pJIV5eHKnc4Pl[EBqdiCqdX3hckBJ\XCJMjDj[YxteyCkeTD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9NE4xODJizszN NFztbGgzOzVyMkKxNi=>
L6 cells NY\hXGx{TnWwY4Tpc44h[XO|YYm= MWeyOEBpenN? NGH2Om5KdmS3Y4Tpc44hd2ZiZ3z1Z49{\SC3cIThb4UhcW5icnH0JGw3KGOnbHzzJJB2dHOnZDD3bZRpKENzND3k[Y95gSCpbIXjc5NmKGGodHXyJFI1KGi{czDpckBxemW|ZX7j[UBw\iCrboP1cIlvNCCHQ{WwQVQvPDlizszN M4XqNFI{QTl{OE[y
L6 cells MoTHSpVv[3Srb36gZZN{[Xl? MXGxOkBpenN? M4XYcWlv[3KnYYPlJIlvKDJvW{PIYU1l\W:6eXfseYNwe2VidYD0ZYtmKGmwIILheEBNPiClZXzsd{Bi\nSncjCxOkBpenNiYomgd4NqdnSrbHzheIlwdiClb4XueIlv\yCjbnHsfZNqeyxiRVO1NF01NjhizszN M2DaUVI1QDF|N{O4
DU145 cells NIHrPVREgXSxdH;4bYNqfHliYYPzZZk> M3y1R|Q5KGi{cx?= MWPDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDEWVE1PSClZXzsd{Bie3Onc4Pl[EBieyCpcn;3eIghcW6qaXLpeIlwdiCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCHQ{WwQVE3KM7:TR?= MYiyOFk6PjF2Mx?=
PC3 cells NGezO|JEgXSxdH;4bYNqfHliYYPzZZk> M{Pub|Q5KGi{cx?= M4LaXWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHBEOyClZXzsd{Bie3Onc4Pl[EBieyCpcn;3eIghcW6qaXLpeIlwdiCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCHQ{WwQVIxNjNizszN MXSyOFk6PjF2Mx?=
MDA-MB-231 cells MYTHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MV[yOEBpenN? NFnZUlZIem:5dHigbY5pcWKrdHnvckBw\iCqdX3hckBOTEFvTVKtNlMyKGOnbHzzJIFnfGW{IEK0JIhzeyCkeTDNWHQh[XO|YYmsJGVEPTB;NT6yN{DPxE1? NYXERmhGOjV{N{iyN|Y>
HEK293 cells MorlSpVv[3Srb36gZZN{[Xl? MYXB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiRVO1NF0xNjBzIN88US=> M1\Xb|I2OzB3Nki4
HepG2 cells NGfLXJJHfW6ldHnvckBie3OjeR?= MmfSNlAhcHK| MYTUdoFve2GldHn2ZZRqd25ib3[gVHBCWiC2cnHud4Zm[3SnZDDpckBpfW2jbjDI[ZBIOiClZXzsd{Bi\nSncjCyNEBpenNiYomgVHBCWi2udXPp[oVz[XOnIHHzd4F6NCCHQ{WwQVEvPiEQvF2= MWOyOVQ{PzNyNB?=
HEK293 cells NG\R[YdHfW6ldHnvckBie3OjeR?= MmjQNlQhcHK| MVTUdoFve2GldHn2ZZRqd25ib3[gVHBCWmejbX3hJEh2dmuwb4fuJI9zcWerbjmg[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczDpcoN2[mG2ZXSg[o9zKDJ2IHjyd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYm= NV;6c5hIOjV2NEKzNlI>
HepG2 cells NH2wdnRHfW6ldHnvckBie3OjeR?= Mmn6RYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDHRWw1NVCSQWLnZY1u[SCuaXfhcoQh[mmwZHnu[{Bld22jaX6g[ZhxemW|c3XkJIlvKGi3bXHuJGhmeEd{IHPlcIx{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhTUN3ME2wMlA{QSEQvF2= NFvGbZIzPTR4MkK4NS=>
HEK293 cells M17rNWZ2dmO2aX;uJIF{e2G7 MWSyOEBpenN? NILTZpFC\2:waYP0JIFkfGm4aYT5JIF1KG2xdYPlJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJINwNWW6cILld5Nqdmdid3n0bEBI[Wx2IILldI9zfGW{II\lZ5RweiCjZoTldkAzPCCqcoOgZpkh\HWjbD3seYNq\mW{YYPlJJJmeG:{dHXyJIF{e2G7LDDFR|UxRTBwMEOg{txO MljKNlQ6PTV6OEm=
HepG2 cells MX7GeY5kfGmxbjDhd5NigQ>? NHL4PVMzOCCqcoO= M4HQW2Fod26rc4SgZYN1cX[rdImgZZQhT0GOND3EUmEh[mmwZHnu[{Bld22jaX6g[pV{\WRiaIXtZY4hWFCDUnfhcY1iKGyrZ3Hu[EBjcW6maX7nJIRwdWGrbjDlfJBz\XO|ZXSgbY4hcHWvYX6gTIVxTzJiY3XscJMh[XO|ZYPz[YQh[XNicnXj[ZB1d3JidILhcpNi[3SrdnH0bY9vKGmwY4XiZZRm\CCob4KgNlAhcHK|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiRVO1NF0xNjB2IN88US=> M1jh[|I2PDl5MUOy
HepaR cells M3vGdGZ2dmO2aX;uJIF{e2G7 M{X5Z|Eh\GG7 Mk[1RYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEhcW5iaIXtZY4hUGWyYWKgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4hUE2JQ2OyJIdmdmViZYjwdoV{e2mxbjDheEAyKHWPIHnuZ5Vj[XSnZDDmc5IhOSCmYYmgZpkheXWjboTpeIF1cX[nIGDDVkBu\XSqb3SgdoVt[XSrdnWgeI8hfW62cnXheIVlKGOxboTyc4w> M1y5RVI2PDl5MUOy
HepaR cells Mn[5SpVv[3Srb36gZZN{[Xl? M2Hu[|EhfU1? NGfXcVcyKGSjeR?= M2TLWGFod26rc4SgZYN1cX[rdImgZZQhWFCDUnfhcY1iKGmwIHj1cYFvKEincHHSJINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKEGQR2DUUFQh\2WwZTDlfJBz\XO|aX;uJIF1KDFidV2gbY5kfWKjdHXkJIZweiBzIHThfUBjgSCzdXHueIl1[XSrdnWgVGNTKG2ndHjv[EBz\WyjdHn2[UB1dyC3boTy[YF1\WRiY3;ueJJwdA>? M4n4cVI2PDl5MUOy
HepaR cells MoDmSpVv[3Srb36gZZN{[Xl? NI\XUJMyKHWP NVWxeY5TOSCmYYm= Mm\ORYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEhcW5iaIXtZY4hUGWyYWKgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4hTkGEUEGg[4Vv\SCneIDy[ZN{cW:wIHH0JFEhfU1iaX7jeYJifGWmIH\vdkAyKGSjeTDifUByfWGwdHn0ZZRqfmViUFPSJI1mfGixZDDy[YxifGm4ZTD0c{B2dnS{ZXH0[YQh[2:wdILvcC=> MXWyOVQ6PzF|Mh?=
HEK293 cells NHXDfXFHfW6ldHnvckBie3OjeR?= MYixNEDPxE1? NFjzcGMzPCCqcoO= M3rzW3Rz[W6|YXP0bZZifGmxbjDv[kBRWEGULXfhcY1iKCi3bnvuc5dvKG:{aXfpckkh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{BifCBzMDD1UUBi\nSncjCyOEBpenNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6 MnjWNlQ5QTByOUC=
C2C12 cells M3PtXmZ2dmO2aX;uJIF{e2G7 MoTrN|Ah|ryP NWPiZ4FvOiCq NWO0UpBnUW6mdXP0bY9vKG:oIEKt[IVwgHlvW{PIYU1odHWlb4PlJJVxfGGtZTDpckBud3W|ZTDDNmMyOiClZXzsd{BifCB|MDD1UUBi\nSncjCyJIhzeyCkeTDsbZF2cWRic3PpcpRqdGyjdHnvckBkd3WwdHnu[{BidmGueYPpdy=> NEfTNGIzPTh|NUWzOy=>
MCF7 cells NFX2NI1HfW6ldHnvckBie3OjeR?= MmD0NVYhcA>? NXqwUoZQSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEhfHKjboPm[YN1\WRiaX6gbJVu[W5iTVPGO{Bk\WyuczDh[pRmeiBzNjDodpMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyPUCuNFg4KM7:TR?= MVWyOlIzPjR7MB?=
HEK293 cells NIq3OVRHfW6ldHnvckBie3OjeR?= M3;ZW|ExKM7:TR?= MUSyOEBp MX3B[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUApfW6tbn;3ckBwemmpaX6pJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOgZZN{\XO|ZXSgZZMhemWlZYD0c5IhfHKjboPhZ5RqfmG2aX;uJIF1KDFyIIXNJIlv[3WkYYTl[EBnd3JiMkSgbJJ{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfS=> M3TpT|I3Ozh2Mki2

... Click to View More Cell Line Experimental Data

Protocol

References

Solubility (25°C)

In vitro DMSO 35 mg/mL (198.67 mM)
Ethanol 35 mg/mL (198.67 mM)
Water Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 176.17
Formula

C10H8O3

CAS No. 90-33-5
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT00225537 Unknown status Chronic Hepatitis C|Chronic Hepatitis B MTmedical Institute of Health|The University of Texas Health Science Center at San Antonio|BioMonde Preparations Limited September 2005 Phase 2
NCT00225537 Unknown status Chronic Hepatitis C|Chronic Hepatitis B MTmedical Institute of Health|The University of Texas Health Science Center at San Antonio|BioMonde Preparations Limited September 2005 Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Related Others Products0

Tags: buy 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) supplier | purchase 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) cost | 4-Methylumbelliferone (4-MU) manufacturer | order 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID